Stonvex
Discover
  • Dashboard
  • World News
  • Stock News
  • Rankings
  • Surge
  • Quant Picks
  • Screener
Markets
  • Heatmap
  • Gainers & Losers
Tools
  • Compare
  • Calendar
  • Community
HomeRankingsScreenerPortfolioCommunity
Stonvex
Log inGet Started
← Back to search

ZBH

Live
Real-time chart · IB-grade AI research · Polygon.io data feed
Set alertSave
  • Overview
  • Financials
  • Filings
  • Short Interest
  • Ownership
  • Ratings
  • Peers
  • Options
  • News
✦
Stonvex AI

ZBH

AI Research Report

Powered by Claude

Ready to analyze ZBH

Runs the full IB-grade framework: Narrative, Reverse DCF, Comps, Sensitivity, and Deal Radar. Takes 20–40 seconds.

Free preview · 3 reports / hour · No sign-up required

Earnings

Next report date, year-over-year trend, and recent quarter history.

Earnings history activates with Polygon. When configured, this panel shows the next report date, consensus EPS/revenue, and the last 4 quarters of actual-vs-estimate.

Quant Grades

6-factor scoring with sector-relative rank. Updated daily.

Quant grades are available for tickers in our scored universe.

Financial statements

Most recent quarterly filings sourced directly from SEC EDGAR.

Financial statements activate with Polygon. The Developer plan includes quarterly and annual filings sourced directly from SEC EDGAR.

Corporate events

Share this analysis

Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.

Stonvex

AI-powered stock research for US equities.

hello@stonvex.com

Product

  • Rankings
  • Quant Picks
  • Screener
  • Markets
  • Compare
  • Calendar

Company

  • About Stonvex
  • Pricing & Plans
  • Community
  • Help & FAQ
  • Contact Us

Legal

  • Terms of Service
  • Privacy Policy
  • Privacy Consent
  • Disclaimer
  • Notices & Updates

© 2026 Stonvex. All rights reserved.

This site is for informational purposes only. Not investment advice. Past performance does not guarantee future results. Stonvex is not a registered investment advisor (RIA). You must be 18 years or older to use this service.

Latest news

Factor Grades

5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.

  • Fintel·1d ago

    Leerink Partners Initiates Coverage of Zimmer Biomet Holdings (ZBH) with Market Perform Recommendation

  • Yahoo·3/9/2026

    Netflix resumed, Starbucks downgraded: Wall Street's top analyst calls

    Netflix resumed, Starbucks downgraded: Wall Street's top analyst calls

  • Yahoo·1d ago

    3 Cash-Producing Stocks We Keep Off Our Radar

    While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

  • Yahoo·4d ago

    Zimmer Biomet’s Quarterly Earnings Preview: What You Need to Know

    Zimmer Biomet is poised to report its first-quarter results in the near future, and Wall Street anticipates a measured, single-digit increase in earnings.

  • Yahoo·5d ago

    Can 13-15% Procedure Growth in 2026 Sustain ISRG's Premium Valuation?

    Intuitive Surgical's 13-15% 2026 procedure growth signals durable demand and global expansion, but macro and policy risks could test its premium valuation.

  • Yahoo·5d ago

    Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results

    Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its first quarter earnings conference call will be webcast on Tuesday, April 28, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.

  • Yahoo·5d ago

    Zimmer Biomet (ZBH) Valuation Check After New Technology Leadership And Robotic Shoulder Surgery Milestones

    Zimmer Biomet Holdings (ZBH) is back in focus after two technology linked milestones: the appointment of a new chief science and technology leader and a high profile robotic assisted shoulder surgery using its ROSA platform in an outpatient setting. See our latest analysis for Zimmer Biomet Holdings. Despite the recent headlines around robotics and leadership changes, momentum in Zimmer Biomet’s shares has been subdued, with a 1-week share price return of 2.2% and a 1-year total shareholder...

  • View all news →
Zimmer Biomet Holdings, Inc

Zimmer Biomet Holdings, Inc

Health Care·NEW YORK STOCK EXCHANGE, INC.·US·IPO 2001-07-25

Factor Grades

View details →
C
Overall score: 53/100
B
Valuation
C-
Growth
C+
Profitability
C-
Momentum
C+
Financial Health

Fundamentals

Valuation
Market Cap
$17.59B
P/E (TTM)
26.40S&P avg ~22
P/S (TTM)
2.26S&P avg ~2.8
P/B
1.40S&P avg ~4.5
P/FCF
16.61S&P avg ~26
EPS (TTM)
$3.55
Book/sh
$64.95
Cash/sh
$3.03
Profitability
Gross Margin
69.71%avg ~45%
Operating Margin
13.34%avg ~15%
Net Margin
8.56%avg ~12%
ROE
5.59%avg ~18%
ROA
3.08%avg ~7%
ROI
3.49%
Payout Ratio
27.01%
FCF/sh
—
Growth & Health
Rev Growth YoY
7.20%
Rev Growth 5Y
3.22%
EPS Growth YoY
-20.07%
EPS Growth 5Y
—
Current Ratio
—
Quick Ratio
0.89
Debt/Equity
—
LT Debt/Eq
—
Trading & Dividends
Beta
0.60
52W High
$108.29
52W Low
$84.59
Avg Vol (10D)
1.89M
Avg Vol (3M)
2.15M
Div Yield
1.04%
Div/sh (TTM)
—
Analyst
Buy (34)
Price Performance
5D+4.31%
MTD+5.44%
3M+1.34%
6M-3.53%
YTD+6.03%
1Y-6.77%
NEW YORK STOCK EXCHANGE, INC.Market closed
Zimmer Biomet Holdings, Inc
Health Care
$96.52
$1.18 (+1.24%)
Open
$95.38
Prev close
$95.34
Day range
$95.09 – $97.81
52W range
$84.59 – $108.29
Mkt cap
$17.59B
P/E
26.4
EPS
$3.55
Beta
0.60
📅 Earnings in 13d (Apr 28)

Analyst Consensus

Buy
Based on 34 analysts
Period: 2026-04-01
11 Buy (32%)20 Hold (59%)3 Sell (9%)
Rating Distribution
Strong Buy
3
Buy
8
Hold
20
Sell
3
Strong Sell
0
Trend
2026-04
11
/
20
/
3
2026-03
12/20/3
2026-02
12/19/3
2026-01
11/20/2

Recent insider activity

View all →
  • 4Insider transaction
    12d ago
  • 4Insider transaction
    13d ago
  • 4Insider transaction
    13d ago
  • 4Insider transaction
    13d ago
  • 4Insider transaction
    13d ago